We achieved this early during manufacturing site in Gouda in the Netherlands* – To gain EXCiPACT certification for five manufacturing sites producing pharmaceutical excipients by the end of 2015 Our Mevisa site in Spain and Rawcliffe Bridge site in the UK have already achieved this target during 2014 Implementation To confirm the implementation status of different standards, all manufacturing sites now have to report against KPIs concerning their quality performance, as well as reporting on their quality management systems and GMP status to the Group Quality function.